TDI |
TDI-1. Trend in estimated number of new clients entering treatment by primary drug used, from 2002 to 2006
Part (i) Percentage distribution by primary drug
|
TDI |
TDI-1. Trend in estimated number of new clients entering treatment by primary drug used, from 2002 to 2006
Part (ii) Numbers of clients by primary drug
|
TDI |
TDI-2. New and all clients entering treatment by primary drug: heroin, cocaine, cannabis, other stimulants, other drugs in 2006 in 24 EU Member States
Part (i) New clients
|
TDI |
TDI-2. New and all clients entering treatment by primary drug: heroin, cocaine, cannabis, other stimulants, other drugs in 2006 in 24 EU Member States
Part (ii) All clients
|
TDI |
TDI-3. Trend in estimated number of all clients entering treatment by primary drug used, from 2002 to 2006
Part (i) Percentage distribution by primary drug
|
TDI |
TDI-3. Trend in estimated number of all clients entering treatment by primary drug used, from 2002 to 2006
Part (ii) Numbers of clients by primary drug
|
TDI |
TDI-6. New and all outpatient clients by age group in 2006 for those countries supplying data
|
TDI |
TDI-7. New outpatient clients injecting opioid as primary drug from 2003 to 2006 in 13 countries supplying data
|
TDI |
TDI-11. Clients entering first treatment, all clients entering treatment, total clients in treatment, summary of nine EU countries reporting in 2006
Part (i) Number of clients in treatment
|
TDI |
TDI-11. Clients entering first treatment, all clients entering treatment, total clients in treatment, summary of nine EU countries reporting in 2006
Part (ii) Percentage of clients in treatment with opioids, cannabis or other drugs as primary drugs
|
TDI |
TDI-1. Data sources for data on clients entering treatment in 2006
|
TDI |
TDI-2. Trends in the number of clients entering treatment and the number of reporting treatment centres, 1996 to 2006
Part (i) Total numbers of new clients entering treatment
|
TDI |
TDI-2. Trends in the number of clients entering treatment and the number of reporting treatment centres, 1996 to 2006
Part (ii) Total numbers of all clients entering treatment
|
TDI |
TDI-2. Trends in the number of clients entering treatment and the number of reporting treatment centres, 1996 to 2006
Part (iii) Numbers of treatment units covered for reporting clients entering treatment
|
TDI |
TDI-2. Trends in the number of clients entering treatment and the number of reporting treatment centres, 1996 to 2006
Part (iv) Types of units covered for reporting clients entering treatment
|
TDI |
TDI-3. Trend of new clients entering treatment by primary drug used, 1993 to 2006
Part (i) Percentage of new clients using heroin
|
TDI |
TDI-3. Trend of new clients entering treatment by primary drug used, 1993 to 2006
Part (ii) Percentage of new clients using cocaine
|
TDI |
TDI-3. Trend of new clients entering treatment by primary drug used, 1993 to 2006
Part (iii) Percentage of new clients using stimulants (amphetamines and MDMA)
|
TDI |
TDI-3. Trend of new clients entering treatment by primary drug used, 1993 to 2006
Part (iv) Percentage of new clients using cannabis
|
TDI |
TDI-4. Characteristics of new clients entering treatment: demographics and primary drug at treatment in 2006 or most recent year available
Part (i) Demographics of new clients entering treatment
|
TDI |
TDI-4. Characteristics of new clients entering treatment: demographics and primary drug at treatment in 2006 or most recent year available
Part (ii) Primary drug type used (percent of new clients using) and of those, the percent injecting it
|
TDI |
TDI-5. Characteristics of all clients entering treatment: demographics and primary drug at treatment in 2006 or most recent year available
Part (i) Demographics of all clients entering treatment
|
TDI |
TDI-5. Characteristics of all clients entering treatment: demographics and primary drug at treatment in 2006 or most recent year available
Part (ii) Primary drug type used by clients (percentage of all clients) and of those, the percentage injecting the drug
|
TDI |
TDI-5. Characteristics of all clients entering treatment: demographics and primary drug at treatment in 2006 or most recent year available
Part (iii) Demographics of all men entering treatment
|
TDI |
TDI-5. Characteristics of all clients entering treatment: demographics and primary drug at treatment in 2006 or most recent year available
Part (iv) Demographics of all women entering treatment
|
TDI |
TDI-5. Characteristics of all clients entering treatment: demographics and primary drug at treatment in 2006 or most recent year available
Part (v) Primary drug type used by male clients (percentage of all male clients)
|
TDI |
TDI-5. Characteristics of all clients entering treatment: demographics and primary drug at treatment in 2006 or most recent year available
Part (vi) Primary drug type used by female clients (percentage of all female clients)
|
TDI |
TDI-6. Incidence of treatment demands for drug use: new clients entering treatment in 2006 (rate per 100 000 population)
|
TDI |
TDI-7. Data coverage in 2006 for countries supplying data
Part (i) Number of new and all clients entering treatment by type of treatment centre
|
TDI |
TDI-7. Data coverage in 2006 for countries supplying data
Part (ii) Number and type of treatment centre
|
TDI |
TDI-8. Amphetamines, ecstasy and other non-cocaine stimulants: primary use among new and all clients entering treatment in 2006 for countries supplying data
Part (i) All clients with primary use of stimulants other than cocaine in treatment centres reported for the country
|
TDI |
TDI-8. Amphetamines, ecstasy and other non-cocaine stimulants: primary use among new and all clients entering treatment in 2006 for countries supplying data
Part (ii) New clients with primary use of stimulants other than cocaine in treatment centres reported for the country
|
TDI |
TDI-9. Mean age and gender distribution among new and all clients entering outpatient treatment in 2006
|
TDI |
TDI-10. Age distribution by primary drug of clients entering treatment — EU overall summary in 2006
Part (i) Percentage distribution of new outpatient clients by age group for each primary drug
|
TDI |
TDI-10. Age distribution by primary drug of clients entering treatment — EU overall summary in 2006
Part (ii) Percentage distribution of new outpatient clients by primary drug for each age group
|
TDI |
TDI-10. Age distribution by primary drug of clients entering treatment — EU overall summary in 2006
Part (iii) Percentage distribution of all outpatient clients by age group for each primary drug
|
TDI |
TDI-10. Age distribution by primary drug of clients entering treatment — EU overall summary in 2006
Part (iv) Percentage distribution of all outpatient clients by primary drug for each age group
|
TDI |
TDI-10. Age distribution by primary drug of clients entering treatment — EU overall summary in 2006
Part (v) Percentage distribution of new inpatient clients by age group for each primary drug
|
TDI |
TDI-10. Age distribution by primary drug of clients entering treatment — EU overall summary in 2006
Part (vi) Percentage distribution of new inpatient clients by primary drug for each age group
|
TDI |
TDI-10. Age distribution by primary drug of clients entering treatment — EU overall summary in 2006
Part (vii) Percentage distribution of all inpatient clients by age group for each primary drug
|
TDI |
TDI-10. Age distribution by primary drug of clients entering treatment — EU overall summary in 2006
Part (viii) Percentage distribution of all inpatient clients by primary drug for each age group
|
TDI |
TDI-11. Age at first use of primary drug among clients according to primary drug for which they enter treatment — EU overall summary in 2006
Part (i) Percentage distribution of new outpatient clients by age at first use for each primary drug
|
TDI |
TDI-11. Age at first use of primary drug among clients according to primary drug for which they enter treatment — EU overall summary in 2006
Part (ii) Percentage distribution of new outpatient clients by primary drug for age at first use
|
TDI |
TDI-11. Age at first use of primary drug among clients according to primary drug for which they enter treatment — EU overall summary in 2006
Part (iii) Percentage distribution of all outpatient clients by age at first use for each primary drug
|
TDI |
TDI-11. Age at first use of primary drug among clients according to primary drug for which they enter treatment — EU overall summary in 2006
Part (iv) Percentage distribution of all outpatient clients by primary drug for age at first use
|
TDI |
TDI-11. Age at first use of primary drug among clients according to primary drug for which they enter treatment — EU overall summary in 2006
Part (v) Percentage distribution of new inpatient clients by age at first use for each primary drug
|
TDI |
TDI-11. Age at first use of primary drug among clients according to primary drug for which they enter treatment — EU overall summary in 2006
Part (vi) Percentage distribution of new inpatient clients by primary drug for age at first use
|
TDI |
TDI-11. Age at first use of primary drug among clients according to primary drug for which they enter treatment — EU overall summary in 2006
Part (vii) Percentage distribution of all inpatient clients by age at first use for each primary drug
|
TDI |
TDI-11. Age at first use of primary drug among clients according to primary drug for which they enter treatment — EU overall summary in 2006
Part (viii) Percentage distribution of all inpatient clients by primary drug for age at first use
|
TDI |
TDI-12. Percentage distribution of educational level for clients entering treatment in 2006
Part (i) New clients entering outpatient treatment
|
TDI |
TDI-12. Percentage distribution of educational level for clients entering treatment in 2006
Part (ii) All clients entering outpatient treatment
|
TDI |
TDI-12. Percentage distribution of educational level for clients entering treatment in 2006
Part (iii) New clients entering inpatient treatment
|
TDI |
TDI-12. Percentage distribution of educational level for clients entering treatment in 2006
Part (iv) All clients entering inpatient treatment
|
TDI |
TDI-13. Percentage distribution of labour status for clients entering treatment in 2006
Part (i) New clients entering outpatient treatment
|
TDI |
TDI-13. Percentage distribution of labour status for clients entering treatment in 2006
Part (ii) All clients entering outpatient treatment
|
TDI |
TDI-13. Percentage distribution of labour status for clients entering treatment in 2006
Part (iii) New clients entering inpatient treatment
|
TDI |
TDI-13. Percentage distribution of labour status for clients entering treatment in 2006
Part (iv) All clients entering inpatient treatment
|
TDI |
TDI-14. Percentage distribution of accommodation arrangements (persons with whom the client is living) of clients entering treatment in 2006
Part (i) New clients entering outpatient treatment
|
TDI |
TDI-14. Percentage distribution of accommodation arrangements (persons with whom the client is living) of clients entering treatment in 2006
Part (ii) All clients entering outpatient treatment
|
TDI |
TDI-14. Percentage distribution of accommodation arrangements (persons with whom the client is living) of clients entering treatment in 2006
Part (iii) New clients entering inpatient treatment
|
TDI |
TDI-14. Percentage distribution of accommodation arrangements (persons with whom the client is living) of clients entering treatment in 2006
Part (iv) All clients entering inpatient treatment
|
TDI |
TDI-15. Percentage distribution of living conditions for clients entering treatment in 2006
Part (i) New clients entering outpatient treatment
|
TDI |
TDI-15. Percentage distribution of living conditions for clients entering treatment in 2006
Part (ii) All clients entering outpatient treatment
|
TDI |
TDI-15. Percentage distribution of living conditions for clients entering treatment in 2006
Part (iii) New clients entering inpatient treatment
|
TDI |
TDI-15. Percentage distribution of living conditions for clients entering treatment in 2006
Part (iv) All clients entering inpatient treatment
|
TDI |
TDI-16. Percentage distribution of source of referral for new clients entering outpatient and inpatient treatment in 2006
Part (i) New clients entering outpatient treatment
|
TDI |
TDI-16. Percentage distribution of source of referral for new clients entering outpatient and inpatient treatment in 2006
Part (ii) New clients entering inpatient treatment
|
TDI |
TDI-17. Route of administration of primary drug among new and all outpatient clients in 2006
Part (i) Percentage distribution of route of administration amongst new clients with opioids as primary drug
|
TDI |
TDI-17. Route of administration of primary drug among new and all outpatient clients in 2006
Part (ii) Percentage distribution of route of administration amongst new clients with cocaine (HCl and crack) as primary drug
|
TDI |
TDI-17. Route of administration of primary drug among new and all outpatient clients in 2006
Part (iii) Percentage distribution of route of administration amongst new clients with stimulants (other than cocaine) as primary drug
|
TDI |
TDI-17. Route of administration of primary drug among new and all outpatient clients in 2006
Part (iv) Percentage distribution of route of administration amongst new clients with hypnotics and sedatives as primary drug
|
TDI |
TDI-17. Route of administration of primary drug among new and all outpatient clients in 2006
Part (v) Percentage distribution of route of administration amongst all clients with opioids as primary drug
|
TDI |
TDI-17. Route of administration of primary drug among new and all outpatient clients in 2006
Part (vi) Percentage distribution of route of administration amongst all clients with cocaine (HCl and crack) as primary drug
|
TDI |
TDI-17. Route of administration of primary drug among new and all outpatient clients in 2006
Part (vii) Percentage distribution of route of administration amongst all clients with stimulants (other than cocaine) as primary drug
|
TDI |
TDI-17. Route of administration of primary drug among new and all outpatient clients in 2006
Part (viii) Percentage distribution of route of administration amongst all clients with hypnotics and sedatives as primary drug
|
TDI |
TDI-18. Frequency of use of primary drug among new and all outpatient and inpatient clients in 2006
Part (i) Percentage distribution amongst new outpatient clients
|
TDI |
TDI-18. Frequency of use of primary drug among new and all outpatient and inpatient clients in 2006
Part (ii) Percentage distribution amongst all outpatient clients
|
TDI |
TDI-18. Frequency of use of primary drug among new and all outpatient and inpatient clients in 2006
Part (iii) Percentage distribution amongst new inpatient clients
|
TDI |
TDI-18. Frequency of use of primary drug among new and all outpatient and inpatient clients in 2006
Part (iv) Percentage distribution amongst all inpatient clients
|
TDI |
TDI-19. Percentage distribution of primary drug among new and all clients entering outpatient and inpatient treatment in 2006
Part (i) New clients entering outpatient treatment
|
TDI |
TDI-19. Percentage distribution of primary drug among new and all clients entering outpatient and inpatient treatment in 2006
Part (ii) All clients entering outpatient treatment
|
TDI |
TDI-19. Percentage distribution of primary drug among new and all clients entering outpatient and inpatient treatment in 2006
Part (iii) New clients entering inpatient treatment
|
TDI |
TDI-19. Percentage distribution of primary drug among new and all clients entering outpatient and inpatient treatment in 2006
Part (iv) All clients entering inpatient treatment
|
TDI |
TDI-20. Unemployment rates among new and all clients entering outpatient and inpatient treatment in 2006 and in the general population
Part (i) New clients entering outpatient treatment
|
TDI |
TDI-20. Unemployment rates among new and all clients entering outpatient and inpatient treatment in 2006 and in the general population
Part (ii) All clients entering outpatient treatment
|
TDI |
TDI-20. Unemployment rates among new and all clients entering outpatient and inpatient treatment in 2006 and in the general population
Part (iii) New clients entering inpatient treatment
|
TDI |
TDI-20. Unemployment rates among new and all clients entering outpatient and inpatient treatment in 2006 and in the general population
Part (iv) All clients entering inpatient treatment
|
TDI |
TDI-21. Gender ratio by primary drug — ratio of males to females among new and all clients entering outpatient and inpatient treatment in 2006
Part (i) Ratio of males to females among new clients entering outpatient treatment
|
TDI |
TDI-21. Gender ratio by primary drug — ratio of males to females among new and all clients entering outpatient and inpatient treatment in 2006
Part (ii) Ratio of males to females among all clients entering outpatient treatment
|
TDI |
TDI-21. Gender ratio by primary drug — ratio of males to females among new and all clients entering outpatient and inpatient treatment in 2006
Part (iii) Ratio of males to females among new clients entering inpatient treatment
|
TDI |
TDI-21. Gender ratio by primary drug — ratio of males to females among new and all clients entering outpatient and inpatient treatment in 2006
Part (iv) Ratio of males to females among all clients entering inpatient treatment
|
TDI |
TDI-22. Secondary drugs: number of citations by all clients in outpatient and inpatient centres in 2006: average for those EU countries supplying data
Part (i) Outpatient centres
|
TDI |
TDI-22. Secondary drugs: number of citations by all clients in outpatient and inpatient centres in 2006: average for those EU countries supplying data
Part (ii) Inpatient centres
|
TDI |
TDI-23. Polydrug use among all clients entering outpatient treatment, for countries supplying data for 2006: opioids, cocaine, cannabis or other stimulants as primary drug type combined with a secondary drug type
Part (i) Percentage distribution of secondary drug by primary drug for the EU overall
|
TDI |
TDI-23. Polydrug use among all clients entering outpatient treatment, for countries supplying data for 2006: opioids, cocaine, cannabis or other stimulants as primary drug type combined with a secondary drug type
Part (ii) All clients with opioids as primary drug type: number of episodes reporting the stated drug as secondary
|
TDI |
TDI-23. Polydrug use among all clients entering outpatient treatment, for countries supplying data for 2006: opioids, cocaine, cannabis or other stimulants as primary drug type combined with a secondary drug type
Part (iii) All clients with cocaine as primary drug type: number of episodes reporting the stated drug as secondary
|
TDI |
TDI-23. Polydrug use among all clients entering outpatient treatment, for countries supplying data for 2006: opioids, cocaine, cannabis or other stimulants as primary drug type combined with a secondary drug type
Part (iv) All clients with cannabis as primary drug: number of episodes reporting the stated drug as secondary
|
TDI |
TDI-23. Polydrug use among all clients entering outpatient treatment, for countries supplying data for 2006: opioids, cocaine, cannabis or other stimulants as primary drug type combined with a secondary drug type
Part (v) All clients with stimulants other than cocaine as primary drug type: number of episodes reporting the stated drug as secondary
|
TDI |
TDI-24. Percentage of clients by type of treatment centres and by primary drug for all and new clients entering treatment in 2006 (outpatient, inpatient and other types of treatment centres)
Part (i) All clients
|
TDI |
TDI-24. Percentage of outpatient and inpatient clients by primary drug for all and new clients entering treatment in 2006
Part (ii) New clients
|
TDI |
TDI-25. Percentage distribution of age by gender among all clients entering outpatient treatment with primary drug: opioids, cocaine, stimulants and cannabis in 2006 for countries supplying data
|
TDI |
TDI-32. Mean age by gender by primary drug among all clients entering outpatient and inpatient treatment in 2006
Part (i) Outpatient clients
|
TDI |
TDI-32. Mean age by gender by primary drug among all clients entering outpatient and inpatient treatment in 2006
Part (ii) Inpatient clients
|
TDI |
TDI-33. Mean age at first use and mean age at entering treatment by gender and primary drug among new clients entering outpatient and inpatient treatment in 2006
Part (i) Outpatient treatment centres
|
TDI |
TDI-33. Mean age at first use and mean age at entering treatment by gender and primary drug among new clients entering outpatient and inpatient treatment in 2006
Part (ii) Inpatient treatment centres
|
TDI |
TDI-34. Outpatient and inpatient treatment centres and treatment units in prison: number of all clients entering treatment and number and percentages of units covered in four countries supplying data in 2006
|
TDI |
TDI-35. Outpatient and inpatient treatment centres and treatment units in prison: percentage distribution of all clients by primary drug in four countries supplying data in 2006
|
TDI |
TDI-36. Trends in primary amphetamines use among new clients entering treatment between 2001 and 2006 in four countries
|
TDI |
TDI-37. Amphetamines and ecstasy clients entering drug treatment in 2006
Part (i) Outpatient and inpatient clients entering treatment for primary amphetamines and ecstasy use in 2006
|
TDI |
TDI-37. Amphetamines and ecstasy clients entering drug treatment in 2006
Part (ii) Mean age and gender ratio among primary amphetamines or ecstasy clients entering treatment in 2006
|
TDI |
TDI-37. Amphetamines and ecstasy clients entering drug treatment in 2006
Part (iii) Secondary drugs among outpatient and inpatient clients entering treatment for primary amphetamines and ecstasy use (number of citations)
|
TDI |
TDI-38. All clients in treatment (treatment prevalence) for primary use of amphetamines, ecstasy and other stimulants (other than cocaine) in countries reporting in 2006: demographics and patterns of drug use
|
TDI |
TDI-39. Treatment prevalence in 2006 in nine countries: percentage distribution of all treatment clients by primary drug at treatment entry (first treatment incidence, total treatment incidence, total treatment prevalence)
|
TDI |
TDI-40. Treatment Prevalence in 2006: proportion of injectors by primary drug (excluding cannabis) among treated clients in 2006 in nine countries (first treatment incidence, total treatment incidence, total treatment prevalence)
|
TDI |
TDI-102. New clients entering outpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data
Part(i) Number of clients using opioids as primary drug
|
TDI |
TDI-102. New clients entering outpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data
Part(ii) Number of clients using cocaine (HCl and 'crack') as primary drug
|
TDI |
TDI-102. New clients entering outpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data
Part(iii) Number of clients using stimulants (other than cocaine) as primary drug
|
TDI |
TDI-102. New clients entering outpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data
Part(iv) Number of clients using hallucinogens as primary drug
|
TDI |
TDI-102. New clients entering outpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data
Part (v) Number of clients using hypnotics and sedatives as primary drug
|
TDI |
TDI-102. New clients entering outpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data
Part (vi) Number of clients using volatile/inhalants as primary drug
|
TDI |
TDI-102. New clients entering outpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data
Part (vii) Number of clients using cannabis as primary drug
|
TDI |
TDI-102. New clients entering outpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data
Part (viii) Number of clients using other drugs as primary drugs
|
TDI |
TDI-103. All clients entering outpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data
Part(i) Number of clients using opioids as primary drug
|
TDI |
TDI-103. All clients entering outpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data
Part(ii) Number of clients using cocaine (HCl and 'crack') as primary drug
|
TDI |
TDI-103. All clients entering outpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data
Part(iii) Number of clients using stimulants (other than cocaine) as primary drug
|
TDI |
TDI-103. All clients entering outpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data
Part(iv) Number of clients using hallucinogens as primary drug
|
TDI |
TDI-103. All clients entering outpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data
Part (v) Number of clients using hypnotics and sedatives as primary drug
|
TDI |
TDI-103. All clients entering outpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data
Part (vi) Number of clients using volatile/inhalants as primary drug
|
TDI |
TDI-103. All clients entering outpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data
Part (vii) Number of clients using cannabis as primary drug
|
TDI |
TDI-103. All clients entering outpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data
Part (viii) Number of clients using other drugs as primary drugs
|
TDI |
TDI-104. New clients entering inpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data
Part(i) Number of clients using opioids as primary drug
|
TDI |
TDI-104. New clients entering inpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data
Part(ii) Number of clients using cocaine (HCl and 'crack') as primary drug
|
TDI |
TDI-104. New clients entering inpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data
Part(iii) Number of clients using stimulants (other than cocaine) as primary drug
|
TDI |
TDI-104. New clients entering inpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data
Part(iv) Number of clients using hallucinogens as primary drug
|
TDI |
TDI-104. New clients entering inpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data
Part (v) Number of clients using hypnotics and sedatives as primary drug
|
TDI |
TDI-104. New clients entering inpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data
Part (vi) Number of clients using volatile/inhalants as primary drug
|
TDI |
TDI-104. New clients entering inpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data
Part (vii) Number of clients using cannabis as primary drug
|
TDI |
TDI-104. New clients entering inpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data
Part (viii) Number of clients using other drugs as primary drugs
|
TDI |
TDI-105. All clients entering inpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data
Part(i) Number of clients using opioids as primary drug
|
TDI |
TDI-105. All clients entering inpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data
Part(ii) Number of clients using cocaine (HCl and 'crack') as primary drug
|
TDI |
TDI-105. All clients entering inpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data
Part(iii) Number of clients using stimulants (other than cocaine) as primary drug
|
TDI |
TDI-105. All clients entering inpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data
Part(iv) Number of clients using hallucinogens as primary drug
|
TDI |
TDI-105. All clients entering inpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data
Part (v) Number of clients using hypnotics and sedatives as primary drug
|
TDI |
TDI-105. All clients entering inpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data
Part (vi) Number of clients using volatile/inhalants as primary drug
|
TDI |
TDI-105. All clients entering inpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data
Part (vii) Number of clients using cannabis as primary drug
|
TDI |
TDI-105. All clients entering inpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data
Part (viii) Number of clients using other drugs as primary drugs
|
TDI |
TDI-106. New clients entering outpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data
Part (i) Number of clients using opiates as primary drug
|
TDI |
TDI-106. New clients entering outpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data
Part (ii) Number of clients using cocaine as primary drug
|
TDI |
TDI-106. New clients entering outpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data
Part (iii) Number of clients using stimulants (other than cocaine) as primary drug
|
TDI |
TDI-106. New clients entering outpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data
Part (iv) Number of clients using hypnotics and sedatives as primary drug
|
TDI |
TDI-106. New clients entering outpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data
Part (v) Number of clients using hallucinogens as primary drug
|
TDI |
TDI-106. New clients entering outpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data
Part (vi) Number of clients using volatile/inhalants as primary drug
|
TDI |
TDI-106. New clients entering outpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data
Part (vii) Number of clients using cannabis as primary drug
|
TDI |
TDI-106. New clients entering outpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data
Part (viii) Number of clients using other drugs as primary drugs
|
TDI |
TDI-107. All clients entering outpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data
Part (i) Number of clients using opiates as primary drug
|
TDI |
TDI-107. All clients entering outpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data
Part (ii) Number of clients using cocaine as primary drug
|
TDI |
TDI-107. All clients entering outpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data
Part (iii) Number of clients using stimulants (other than cocaine) as primary drug
|
TDI |
TDI-107. All clients entering outpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data
Part (iv) Number of clients using hypnotics and sedatives as primary drug
|
TDI |
TDI-107. All clients entering outpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data
Part (v) Number of clients using hallucinogens as primary drug
|
TDI |
TDI-107. All clients entering outpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data
Part (vi) Number of clients using volatile/inhalants as primary drug
|
TDI |
TDI-107. All clients entering outpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data
Part (vii) Number of clients using cannabis as primary drug
|
TDI |
TDI-107. All clients entering outpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data
Part (viii) Number of clients using other drugs as primary drugs
|
TDI |
TDI-108. New clients entering inpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data
Part (i) Number of clients using opioids as primary drug
|
TDI |
TDI-108. New clients entering inpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data
Part (ii) Number of clients using cocaine as primary drug
|
TDI |
TDI-108. New clients entering inpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data
Part (iii) Number of clients using stimulants (other than cocaine) as primary drug
|
TDI |
TDI-108. New clients entering inpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data
Part (iv) Number of clients using hypnotics and sedatives as primary drug
|
TDI |
TDI-108. New clients entering inpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data
Part (v) Number of clients using hallucinogens as primary drug
|
TDI |
TDI-108. New clients entering inpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data
Part (vi) Number of clients using volatile/inhalants as primary drug
|
TDI |
TDI-108. New clients entering inpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data
Part (vii) Number of clients using cannabis as primary drug
|
TDI |
TDI-108. New clients entering inpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data
Part (viii) Number of clients using other drugs as primary drugs
|
TDI |
TDI-109. All clients entering inpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data
Part (i) Number of clients using opiates as primary drug
|
TDI |
TDI-109. All clients entering inpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data
Part (ii) Number of clients using cocaine as primary drug
|
TDI |
TDI-109. All clients entering inpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data
Part (iii) Number of clients using stimulants (other than cocaine) as primary drug
|
TDI |
TDI-109. All clients entering inpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data
Part (iv) Number of clients using hypnotics and sedatives as primary drug
|
TDI |
TDI-109. All clients entering inpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data
Part (v) Number of clients using hallucinogens as primary drug
|
TDI |
TDI-109. All clients entering inpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data
Part (vi) Number of clients using volatile inhalants as primary drug
|
TDI |
TDI-109. All clients entering inpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data
Part (vii) Number of clients using cannabis as primary drug
|
TDI |
TDI-109. All clients entering inpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data
Part (viii) Number of clients using other drugs as primary drugs
|
TDI |
TDI-111. Frequency of use of primary drug among new and all outpatient clients in 2006
Part (i) Percentage distribution amongst new clients with opioids as primary drug
|
TDI |
TDI-111. Frequency of use of primary drug among new and all outpatient clients in 2006
Part (ii) Percentage distribution amongst all clients with opioids as primary drug
|
TDI |
TDI-111. Frequency of use of primary drug among new and all outpatient clients in 2006
Part (iii) Percentage distribution amongst new clients with cannabis as primary drug
|
TDI |
TDI-111. Frequency of use of primary drug among new and all outpatient clients in 2006
Part (iv) Percentage distribution amongst all clients with cannabis as primary drug
|
TDI |
TDI-111. Frequency of use of primary drug among new and all outpatient clients in 2006
Part (v) Percentage distribution amongst new clients with amphetamines and MDMA as primary drug
|
TDI |
TDI-111. Frequency of use of primary drug among new and all outpatient clients in 2006
Part (vi) Percentage distribution amongst all clients with amphetamines and MDMA as primary drug
|
TDI |
TDI-111. Frequency of use of primary drug among new and all outpatient clients in 2006
Part (vii) Percentage distribution amongst new clients with cocaine as primary drug
|
TDI |
TDI-111. Frequency of use of primary drug among new and all outpatient clients in 2006
Part (viii) Percentage distribution amongst all clients with cocaine as primary drug
|
TDI |
TDI-112. Frequency of use of primary drug among new and all inpatient clients in 2006
Part (i) Percentage distribution amongst new clients with opioids as primary drug
|
TDI |
TDI-112. Frequency of use of primary drug among new and all inpatient clients in 2006
Part (ii) Percentage distribution amongst all clients with opioids as primary drug
|
TDI |
TDI-112. Frequency of use of primary drug among new and all inpatient clients in 2006
Part (iii) Percentage distribution amongst new clients with cannabis as primary drug
|
TDI |
TDI-112. Frequency of use of primary drug among new and all inpatient clients in 2006
Part (iv) Percentage distribution amongst all clients with cannabis as primary drug
|
TDI |
TDI-112. Frequency of use of primary drug among new and all inpatient clients in 2006
Part (v) Percentage distribution amongst new clients with amphetamines and MDMA as primary drug
|
TDI |
TDI-112. Frequency of use of primary drug among new and all inpatient clients in 2006
Part (vi) Percentage distribution amongst all clients with amphetamines and MDMA as primary drug
|
TDI |
TDI-112. Frequency of use of primary drug among new and all inpatient clients in 2006
Part (vii) Percentage distribution amongst new clients with cocaine as primary drug
|
TDI |
TDI-112. Frequency of use of primary drug among new and all inpatient clients in 2006
Part (viii) Percentage distribution amongst all clients with cocaine as primary drug
|
TDI |
TDI-113. All clients entering treatment for opioids by type of opioid misused for countries supplying data in 2006
|
TDI |
TDI-114. Primary opioids distribution (percent) among all clients entering treatment by type of treatment centre in three countries supplying data in 2006
|
TDI |
TDI-115. Primary cocaine use – HCL and Crack – among new and all clients entering outpatient drug treatment in 2006 for countries supplying data
Part (i) All clients
|
TDI |
TDI-115. Primary cocaine use – HCL and Crack – among new and all clients entering outpatient drug treatment in 2006 for countries supplying data
Part (ii) New clients
|